Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 2, 2010, Pages 387-394

  Stiles, Brendon M ^a   Christos, Paul ^a   Port, Jeffrey L ^a   Lee, Paul C ^a   Paul, Subroto ^a   Saunders, James ^a   Altorki, Nasser K ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE CLASSIFICATION; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 74649087196     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.10.003     Document Type: Article

References (21)

1. Gebski V., Burmeister B., Smithers B.M., Foo K., Zalcberg J., and Simes J. Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8 (2007) 226-234
2. Bates B.A., Detterbeck F., Bernard S.A., Qaqish B.F., and Tepper J.E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14 (1996) 156-163
3. Stahl M., Wilke H., Fink U., Stuschke M., Walz M.K., Siewert J.R., et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 14 (1996) 829-837
4. Urba S.G., Orringer M., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
5. Seydel H.G., Leichman L., Byhardt R., Cooper J., Herskovic A., Libnock J., et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study. Int J Radiat Oncol Biol Phys 14 (1988) 33-35
6. Rizk N.P., Venkatraman E., Bains M.S., Park B., Flores R., Tang L., et al. American Joint Committee on Cancer. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25 (2007) 507-512
7. Donahue J.M., Nichols F., Li Z., Schomas D.A., Allen M.S., Cassivi S.D., et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 87 (2009) 392-398 discussion 398-399
8. Luu T.D., Gaur P., Force S.D., Staley C.A., Mansour K.A., Miller Jr. J.I., et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg 85 (2008) 1217-1223 discussion 1223-1224
9. Altorki N., and Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 234 (2001) 581-587
10. Gu Y., Swisher S., Ajani J.A., Correa A.M., Hofstetter W.L., Liao Z., et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106 (2006) 1017-1025
11. Trovo M., Bradley J., El Naqa I., Foster E., Meyers B., Govindan R., et al. Esophageal carcinoma with celiac nodal metastases: curative or palliative?. J Thorac Oncol 3 (2008) 751-755
12. Chirieac L.R., Swisher S., Ajani J.A., Komaki R.R., Correa A.M., Morris J.S., et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103 (2005) 1347-1355
13. Lee PC, Port JL, Paul S, Stiles BM, Altorki NK. Predictors of long-term survival following resection of esophageal carcinoma with non-regional nodalmetastases. Ann Thorac Surg. In press.
14. Rizzetto C., DeMeester S., Hagen J.A., Peyre C.G., Lipham J.C., and DeMeester T.R. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg 135 (2008) 1228-1236
15. Altorki N.K., Zhou X., Stiles B., Port J.L., Paul S., Lee P.C., et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248 (2008) 221-226
16. Schwarz R.E., and Smith D. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 11 (2007) 1384-1393 discussion 1393-1394
17. Peyre C.G., Hagen J., DeMeester S.R., Altorki N.K., Ancona E., Griffin S.M., et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248 (2008) 549-556
18. DeMeester S.R. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 13 (2006) 12-30
19. Bédard E.L., Inculet R., Malthaner R.A., Brecevic E., Vincent M., and Dar R. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91 (2001) 2423-2430
20. Rice T.W., Adelstein D., Chidel M.A., Rybicki L.A., DeCamp M.M., Murthy S.C., et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 126 (2003) 1590-1596
21. Cunningham D., Allum W., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20